A metaregression analysis of the dose-response effect of aspirin on stroke.
about
Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN893Aggrenox((R)) versus other pharmacotherapy in preventing recurrent strokeAntiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of useAntithrombotic drugs for secondary stroke prophylaxisIndividual dosing of ASA prophylaxis by controlling platelet aggregationIschemic stroke prevention: an update on antiplatelet therapyAspirin resistanceDose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysisEffect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysisStroke management.Aspirin for acute stroke of unknown etiology in resource-limited settings: a decision analysis.Aspirin for secondary prevention after stroke of unknown etiology in resource-limited settings.Hyperglycemia / hypoglycemia-induced mitochondrial dysfunction and cerebral ischemic damage in diabeticsPharmacological interventions for stroke: failures and future.Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis.Single administration of intra-articular bupivacaine in arthroscopic knee surgery: a systematic review and meta-analysisAspirin resistance in the acute stages of acute ischemic stroke is associated with the development of new ischemic lesions.Platelet-leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke.Current and future concepts in stroke prevention.Peer education for secondary stroke prevention in inner-city minorities: design and methods of the prevent recurrence of all inner-city strokes through education randomized controlled trialCurrent guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.Point-of-care testing for assessment of adequacy of oral antiplatelet therapy in patients with cardiovascular disease.Cost-effectiveness of antiplatelet therapy for secondary stroke prevention.Antithrombotics for secondary prevention of noncardioembolic ischaemic stroke.Secondary prevention of stroke: Pleiotropic effects of optimal oral pharmacotherapy.Antiplatelet treatment in the secondary prevention of coronary and cerebrovascular disease: is there any place for novel agents?Transient ischemic attack and stroke in systemic lupus erythematosus.Efficacy versus safety: the dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease.Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper.Antiplatelet therapies for secondary stroke prevention: an update on clinical and cost-effectiveness.When a Single Antiplatelet Agent for Stroke Prevention Is Not Enough: Current Evidence and Future Applications of Dual Antiplatelet Therapy.Cost-Effectiveness of Proton Pump Inhibitor Co-Therapy in Patients Taking Aspirin for Secondary Prevention of Ischemic Stroke.Aspirin, like all other drugs, is a poison.Evidence-based sample size estimation based upon an updated meta-regression analysis.Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.A survey on adherence to secondary ischemic stroke prevention.Survival and time to initiation of adjuvant chemotherapy among breast cancer patients: a systematic review and meta-analysis.Dose-time-response modeling using negative binomial distribution.The IRIS (Insulin Resistance Intervention after Stroke) trial: A new perspective on pioglitazone.
P2860
Q24801915-D73AFD1F-1BAD-4E73-905B-B65D581F2C26Q28166526-9229D76E-FCB1-4348-8EB0-0BD15D5E52D2Q28167899-A9D19572-13A2-44A9-BCA1-947B8DD0078DQ28182045-9AE1AAEC-D0C2-4427-991A-DF5C14D44137Q28186213-35640EF1-1E0F-4B0F-B6EF-390099E64C92Q28193224-57321240-B221-4EEC-8BE2-7323B1AC66FAQ28193808-CDEF9DCF-985F-4952-BBAF-374F4A47507CQ28345332-890D673E-C1FA-46CC-8E9E-279A7B22A3ABQ33268258-CF10889F-D374-4566-9812-AC4FFA24FC38Q33928297-C6E066C1-8762-448F-83DA-A76C13597E5FQ34135718-FC6D509B-5A79-4009-85CB-27CCA0918EFAQ34170991-6498E964-F2AA-4F1F-985E-C4801FEB5794Q34353546-F392EE24-0ADA-47A9-A46A-5CF9620FE415Q34628650-BCBC9BA1-788A-46B2-8E8C-6066C0E4066BQ34725707-B49F4245-5490-4163-B035-BEBC863BAB77Q35083433-72B58388-D453-43DE-93E9-3EBBE33DAABDQ35301978-B00B3E32-BD6F-497A-8624-4935632402B1Q35633718-F054BEB3-D046-4BBF-9183-DDEC40D3E84BQ35722818-B63E8E5D-1714-47FD-B32D-645406DC8539Q36129396-1BFFB984-4728-436E-AA1F-584A0975505FQ37702726-F00DACEF-C008-4D74-8226-CA6B52A599BBQ37749813-530711A2-ABD2-4E77-A7EF-C04469B272C3Q37763143-BCA2815B-5794-4FAC-B0AA-7BF06A5C7A71Q37992812-E8A004B8-BA57-406B-AFE9-3A709D1FF869Q38051636-79949ED6-470C-479B-B83B-CFC4A17564A1Q38130659-BD93FE02-39B0-4A68-8D13-DA31888DBC97Q38149851-F040B5D4-6363-46F5-A6DA-8FE183DEC0D9Q38213705-10006209-12E9-4322-B0DA-F6C11C368A00Q38229559-AB3D4D06-FA21-4BD8-A458-EDFF33A8178BQ38566809-78C795D4-B53A-4DCE-8086-79FD63854A45Q38904060-6F520B9F-1B16-47B7-9BD1-0E7E1292E3C1Q41725713-807EF8BE-5242-44A8-A3B2-512593CFFE2CQ42769224-D75A2874-18F6-40A2-92D4-BBB3C07C76F1Q47269769-D5BD5B2A-9DF8-4523-9140-ABF329B8EFD7Q47657861-C5582E3B-2BD1-4CD3-BEB7-2A6F7D90B9ACQ48658232-F12FC271-86BA-424A-978A-1812A142AF88Q49242858-E0AC1E4F-5DA0-4321-8298-E3F71DAD86BBQ52761314-1A393A66-DC01-4EA3-9D38-71EDB6FF7DBEQ53788212-B87E428E-CBAA-4438-898C-4F8DD9FA291F
P2860
A metaregression analysis of the dose-response effect of aspirin on stroke.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A metaregression analysis of the dose-response effect of aspirin on stroke.
@ast
A metaregression analysis of the dose-response effect of aspirin on stroke.
@en
type
label
A metaregression analysis of the dose-response effect of aspirin on stroke.
@ast
A metaregression analysis of the dose-response effect of aspirin on stroke.
@en
prefLabel
A metaregression analysis of the dose-response effect of aspirin on stroke.
@ast
A metaregression analysis of the dose-response effect of aspirin on stroke.
@en
P2093
P1476
A metaregression analysis of the dose-response effect of aspirin on stroke.
@en
P2093
Johnson ES
Satterfield MH
Wentworth CE 3rd
P304
P356
10.1001/ARCHINTE.159.11.1248
P407
P577
1999-06-01T00:00:00Z